Correlation Between Praxis Precision and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Praxis Precision and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Praxis Precision and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Praxis Precision Medicines and Virax Biolabs Group, you can compare the effects of market volatilities on Praxis Precision and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Praxis Precision with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Praxis Precision and Virax Biolabs.
Diversification Opportunities for Praxis Precision and Virax Biolabs
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Praxis and Virax is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Praxis Precision Medicines and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Praxis Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Praxis Precision Medicines are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Praxis Precision i.e., Praxis Precision and Virax Biolabs go up and down completely randomly.
Pair Corralation between Praxis Precision and Virax Biolabs
Given the investment horizon of 90 days Praxis Precision Medicines is expected to generate 0.54 times more return on investment than Virax Biolabs. However, Praxis Precision Medicines is 1.86 times less risky than Virax Biolabs. It trades about -0.02 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about -0.11 per unit of risk. If you would invest 7,952 in Praxis Precision Medicines on November 2, 2024 and sell it today you would lose (332.00) from holding Praxis Precision Medicines or give up 4.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Praxis Precision Medicines vs. Virax Biolabs Group
Performance |
| Timeline |
| Praxis Precision Med |
| Virax Biolabs Group |
Praxis Precision and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Praxis Precision and Virax Biolabs
The main advantage of trading using opposite Praxis Precision and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Praxis Precision position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Praxis Precision vs. Molecular Partners AG | Praxis Precision vs. Mineralys Therapeutics, Common | Praxis Precision vs. AN2 Therapeutics | Praxis Precision vs. Pharvaris BV |
| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |